University Of Notre Dame Du Lac Atara Biotherapeutics, Inc. Transaction History

University Of Notre Dame Du Lac

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $5.22 Million - $11.3 Million	-274,229 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $105,392 - $154,897	-3,711 Reduced 1.34%	274,229 $10.9 Million
Q4 2018 Feb 13, 2019	BUY	$30.9 - $42.97 $6.36 Million - $8.84 Million	205,752 Added 285.02%	277,940 $9.66 Million
Q3 2018 Nov 13, 2018	SELL	$35.05 - $43.5 $6.23 Million - $7.73 Million	-177,743 Reduced 71.12%	72,188 $2.99 Million
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $6.92 Million - $10.1 Million	196,783 Added 370.25%	249,931 $9.19 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $956,664 - $2.57 Million	53,148 New	53,148 $2.07 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.